Glycoprotein IIb/IIIa inhibitors

Revision as of 12:35, 28 April 2024 by Nikolas (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Glycoprotein IIb/IIIa inhibitors are antiplatelets. They are mostly used for short-term treatment before and during percutaneous coronary intervention. They are administered by i.v. injection,

Compounds

  • Abciximab
  • Eptifibatide
  • Tirofiban

Mechanism of action

These drugs bind to and inhibit the receptors glycoprotein IIb/IIIa, which prevents platelets from binding to each other and therefore preventing aggregation.